Microbot Medical Inc (MBOT) - Net Assets
Based on the latest financial reports, Microbot Medical Inc (MBOT) has net assets worth $74.11 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($78.07 Million) and total liabilities ($3.96 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MBOT PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $74.11 Million |
| % of Total Assets | 94.93% |
| Annual Growth Rate | 4.97% |
| 5-Year Change | 439.28% |
| 10-Year Change | 4472.76% |
| Growth Volatility | 534.36 |
Microbot Medical Inc - Net Assets Trend (1991–2025)
This chart illustrates how Microbot Medical Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Microbot Medical Inc market capitalisation.
Annual Net Assets for Microbot Medical Inc (1991–2025)
The table below shows the annual net assets of Microbot Medical Inc from 1991 to 2025. Also explore net asset growth rate of Microbot Medical Inc to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $77.55 Million | +2097.00% |
| 2024-12-31 | $3.53 Million | -21.57% |
| 2023-12-31 | $4.50 Million | -38.25% |
| 2022-12-31 | $7.29 Million | -49.32% |
| 2021-12-31 | $14.38 Million | -40.84% |
| 2020-12-31 | $24.31 Million | -22.93% |
| 2019-12-31 | $31.54 Million | +2271.43% |
| 2018-12-31 | $1.33 Million | -86.65% |
| 2017-12-31 | $9.96 Million | +487.50% |
| 2016-12-31 | $1.70 Million | +607.78% |
| 2015-12-31 | $-334.00K | -105.69% |
| 2014-12-31 | $5.87 Million | -60.74% |
| 2013-12-31 | $14.95 Million | +6.93% |
| 2012-12-31 | $13.98 Million | +30.39% |
| 2011-12-31 | $10.73 Million | -30.72% |
| 2010-12-31 | $15.48 Million | -49.24% |
| 2009-12-31 | $30.50 Million | +39.83% |
| 2008-12-31 | $21.81 Million | -38.06% |
| 2007-12-31 | $35.21 Million | -35.24% |
| 2006-12-31 | $54.38 Million | +67.95% |
| 2005-12-31 | $32.38 Million | -12.38% |
| 2004-12-31 | $36.95 Million | +237.02% |
| 2003-12-31 | $10.96 Million | +189.46% |
| 2002-12-31 | $3.79 Million | -71.32% |
| 2001-12-31 | $13.21 Million | -42.53% |
| 2000-12-31 | $22.98 Million | +555.43% |
| 1999-12-31 | $3.51 Million | -80.41% |
| 1998-12-31 | $17.90 Million | -38.06% |
| 1997-12-31 | $28.90 Million | -16.71% |
| 1996-12-31 | $34.70 Million | -23.57% |
| 1995-12-31 | $45.40 Million | +100.88% |
| 1994-12-31 | $22.60 Million | -34.49% |
| 1993-12-31 | $34.50 Million | +18.15% |
| 1992-12-31 | $29.20 Million | +95.97% |
| 1991-12-31 | $14.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Microbot Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9278600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $672.00K | 0.87% |
| Other Components | $180.97 Million | 233.34% |
| Total Equity | $77.55 Million | 100.00% |
Microbot Medical Inc Competitors by Market Cap
The table below lists competitors of Microbot Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Miwon Holdings Co. Ltd
KO:107590
|
$95.40 Million |
|
KGL Resources Ltd
AU:KGL
|
$95.45 Million |
|
Caturkarda Depo Bangunan PT Tbk
JK:DEPO
|
$95.49 Million |
|
Immunoprecise Antibodies Ltd
NASDAQ:IPA
|
$95.54 Million |
|
Investcorp India Acquisition Corp. Class A ordinary share
NASDAQ:IVCA
|
$95.33 Million |
|
AVer Information Inc
TW:3669
|
$95.29 Million |
|
Namsun Alumini
KO:008350
|
$95.26 Million |
|
Fortune Mate Indonesia Tbk
JK:FMII
|
$95.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Microbot Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,530,000 to 77,554,000, a change of 74,024,000 (2097.0%).
- Net loss of 13,142,000 reduced equity.
- New share issuances of 86,239,000 increased equity.
- Other factors increased equity by 927,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-13.14 Million | -16.95% |
| Share Issuances | $86.24 Million | +111.2% |
| Other Changes | $927.00K | +1.2% |
| Total Change | $- | 2097.00% |
Book Value vs Market Value Analysis
This analysis compares Microbot Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.84x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.84x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1991-12-31 | $38303.34 | $1.42 | x |
| 1992-12-31 | $60455.49 | $1.42 | x |
| 1993-12-31 | $53405.57 | $1.42 | x |
| 1994-12-31 | $33284.24 | $1.42 | x |
| 1995-12-31 | $48504.27 | $1.42 | x |
| 1996-12-31 | $36033.23 | $1.42 | x |
| 1997-12-31 | $33816.43 | $1.42 | x |
| 1998-12-31 | $15854.74 | $1.42 | x |
| 1999-12-31 | $3030.60 | $1.42 | x |
| 2000-12-31 | $18563.83 | $1.42 | x |
| 2001-12-31 | $9121.41 | $1.42 | x |
| 2002-12-31 | $2445.17 | $1.42 | x |
| 2003-12-31 | $5537.15 | $1.42 | x |
| 2004-12-31 | $12067.13 | $1.42 | x |
| 2005-12-31 | $8242.26 | $1.42 | x |
| 2006-12-31 | $11808.04 | $1.42 | x |
| 2007-12-31 | $7151.08 | $1.42 | x |
| 2008-12-31 | $4271.25 | $1.42 | x |
| 2009-12-31 | $4658.58 | $1.42 | x |
| 2010-12-31 | $2033.98 | $1.42 | x |
| 2011-12-31 | $1224.75 | $1.42 | x |
| 2012-12-31 | $786.01 | $1.42 | x |
| 2013-12-31 | $557.92 | $1.42 | x |
| 2014-12-31 | $154.37 | $1.42 | x |
| 2015-12-31 | $-4.56 | $1.42 | x |
| 2016-12-31 | $1.78 | $1.42 | x |
| 2017-12-31 | $1.12 | $1.42 | x |
| 2018-12-31 | $0.15 | $1.42 | x |
| 2019-12-31 | $7.39 | $1.42 | x |
| 2020-12-31 | $3.42 | $1.42 | x |
| 2021-12-31 | $2.02 | $1.42 | x |
| 2022-12-31 | $1.00 | $1.42 | x |
| 2023-12-31 | $0.44 | $1.42 | x |
| 2024-12-31 | $0.23 | $1.42 | x |
| 2025-12-31 | $1.69 | $1.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Microbot Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -16.95%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.05x
- Recent ROE (-16.95%) is above the historical average (-144.98%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1991 | -42.95% | -1280.00% | 0.03x | 1.16x | $-7.89 Million |
| 1992 | -34.25% | -714.29% | 0.04x | 1.21x | $-12.92 Million |
| 1993 | -36.23% | -416.67% | 0.07x | 1.19x | $-15.95 Million |
| 1994 | -73.01% | -1269.23% | 0.04x | 1.42x | $-18.76 Million |
| 1995 | -19.60% | -75.42% | 0.21x | 1.25x | $-13.44 Million |
| 1996 | -39.77% | -194.37% | 0.12x | 1.68x | $-17.27 Million |
| 1997 | -51.71% | -170.75% | 0.24x | 1.27x | $-21.60 Million |
| 1998 | -70.39% | -143.13% | 0.27x | 1.84x | $-14.39 Million |
| 1999 | -448.01% | -312.80% | 0.32x | 4.50x | $-16.06 Million |
| 2000 | -49.35% | -15263.80% | 0.00x | 1.30x | $-13.64 Million |
| 2001 | -26.09% | -427.95% | 0.04x | 1.58x | $-4.77 Million |
| 2002 | -273.66% | -2495.32% | 0.04x | 2.99x | $-10.74 Million |
| 2003 | -112.11% | -4495.12% | 0.01x | 1.80x | $-13.39 Million |
| 2004 | -41.49% | -10869.72% | 0.00x | 1.29x | $-19.02 Million |
| 2005 | -36.26% | -5700.44% | 0.00x | 1.38x | $-14.98 Million |
| 2006 | -34.85% | -20407.11% | 0.00x | 1.23x | $-24.39 Million |
| 2007 | -71.06% | -44115.16% | 0.00x | 1.37x | $-28.54 Million |
| 2008 | -133.37% | -12552.11% | 0.01x | 1.89x | $-31.27 Million |
| 2009 | -88.62% | -2722.01% | 0.02x | 1.68x | $-30.08 Million |
| 2010 | -163.07% | -1769.03% | 0.05x | 1.98x | $-26.79 Million |
| 2011 | -198.87% | -1746.85% | 0.05x | 2.35x | $-22.40 Million |
| 2012 | -203.73% | -2082.68% | 0.05x | 2.16x | $-29.89 Million |
| 2013 | -176.80% | -2197.77% | 0.03x | 2.78x | $-27.93 Million |
| 2014 | -557.67% | -3235.28% | 0.03x | 5.52x | $-33.33 Million |
| 2015 | 0.00% | -31123.93% | 0.01x | 0.00x | $-36.38 Million |
| 2016 | -569.75% | 0.00% | 0.00x | 1.99x | $-9.83 Million |
| 2017 | -76.16% | 0.00% | 0.00x | 1.11x | $-8.59 Million |
| 2018 | -545.86% | 0.00% | 0.00x | 4.58x | $-7.39 Million |
| 2019 | -22.98% | 0.00% | 0.00x | 1.18x | $-10.40 Million |
| 2020 | -37.72% | 0.00% | 0.00x | 1.08x | $-11.60 Million |
| 2021 | -78.67% | 0.00% | 0.00x | 1.17x | $-12.75 Million |
| 2022 | -180.66% | 0.00% | 0.00x | 1.31x | $-13.90 Million |
| 2023 | -238.61% | 0.00% | 0.00x | 1.85x | $-11.19 Million |
| 2024 | -324.16% | 0.00% | 0.00x | 1.71x | $-11.80 Million |
| 2025 | -16.95% | 0.00% | 0.00x | 1.05x | $-20.90 Million |
Industry Comparison
This section compares Microbot Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $638,670,729
- Average return on equity (ROE) among peers: -85.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Microbot Medical Inc (MBOT) | $74.11 Million | -42.95% | 0.05x | $95.37 Million |
| Abbott Laboratories (ABT) | $4.40 Billion | 38.41% | 1.14x | $177.76 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $11.55 Million |
| Aethlon Medical Inc (AEMD) | $-9.30 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-131.82 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $780.04 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $1.53 Million | -361.86% | 1.36x | $4.88 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $1.19 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.16 Million |
| Artivion Inc (AORT) | $79.80 Million | -34.79% | 0.33x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $127.64 Million |
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more